AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20130863 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic levothyroxine (LT4) treatment (75‐125 microg/day) among iodine-sufficient patients
Number of subjects: 150
Study 20130863 — intervention group
Group type: COMPARATOR
Intervention: No postoperative LT4 treatment among iodine-sufficient patients
Number of subjects: 150
Study 18397716 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mizoribine (MZB) pulse therapy, 10.0-19.7 mg/kg/d, maximum total dose 750 mg, given twice a week before a meal
Number of subjects: 16
Study 18397716 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mizoribine (MZB) pulse therapy
Number of subjects: 16
Study 15850469 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alpha-2b 1.5 mcg/kg plus oral ribavirin (1000 or 1200 mg/day)
Number of subjects: 153
Study 15850469 — intervention group
Group type: COMPARATOR
Intervention: interferon alpha-2b 3 MU t.i.w. plus ribavirin
Number of subjects: 153
Study 15850469 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alpha-2b plus ribavirin
Number of subjects: 153
Study 15850469 — intervention group
Group type: COMPARATOR
Intervention: interferon alpha-2b plus ribavirin
Number of subjects: 153
Study 12209378 — intervention group
Group type: EXPERIMENTAL
Intervention: High-vegetable diet
Number of subjects: 37
Study 12209378 — intervention group
Group type: COMPARATOR
Intervention: Baseline period (habitual diets)
Number of subjects: 37
Study 12209378 — intervention group
Group type: COMPARATOR
Intervention: All study periods
Number of subjects: 37
Study 10467191 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial catheterization
Number of subjects: 200
Study 7598771 — intervention group
Group type: EXPERIMENTAL
Intervention: vCP125 (10^6 TCID50) followed by rgp160 formulated in alum
Number of subjects: 20
Study 7598771 — intervention group
Group type: EXPERIMENTAL
Intervention: vCP125 (10^6 TCID50)
Number of subjects: 20
Study 7598771 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160 booster injections
Number of subjects: 20
Study 7598771 — intervention group
Group type: COMPARATOR
Intervention: rgp160 formulated in alum or in Freund's incomplete adjuvant (FIA)
Number of subjects: 20
Study 2164070 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lonapalene ointment
Number of subjects: 10
Study 2164070 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 10
Study 567008 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish diet (mackerel)
Number of subjects: 42
Study 567008 — intervention group
Group type: COMPARATOR
Intervention: Control diet (full-fat cheese)
Number of subjects: 42
Study 30767639 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care programme
Number of subjects: 61
Study 30888959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy for 23 months following one-month dual antiplatelet therapy (DAPT)
Number of subjects: 15991
Study 30888959 — intervention group
Group type: COMPARATOR
Intervention: 12-month DAPT followed by 12-month aspirin monotherapy
Number of subjects: 15991
Study 27883927 — intervention group
Group type: EXPERIMENTAL
Intervention: ASH-P (cognitive-behavioral family-based alcohol, DSH, and HIV prevention program)
Number of subjects: 81
Study 26089029 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet (60 mg)
Number of subjects: 18
Study 26089029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 26089029 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (20 mg)
Number of subjects: 18
Study 25252853 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone and web-based psychotherapy intervention
Number of subjects: 720
Study 25252853 — intervention group
Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 720
Study 22643014 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention promoting healthy weight development
Number of subjects: 1418
Study 19220754 — intervention group
Group type: EXPERIMENTAL
Intervention: exendin(9‐39)
Number of subjects: 10
Study 19220754 — intervention group
Group type: COMPARATOR
Intervention: atropine
Number of subjects: 10
Study 16839698 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Therapy group (n=27) with MEMS feedback and compliance enhancement counseling using CBT techniques
Number of subjects: 55
Study 16839698 — intervention group
Group type: COMPARATOR
Intervention: Usual Care group (n=28) receiving weekly individual smoking cessation sessions only
Number of subjects: 55
Study 16839698 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 55
Study 15611571 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone administration (testosterone enanthate, 600 mg/wk intramuscularly)
Number of subjects: 53
Study 15611571 — intervention group
Group type: COMPARATOR
Intervention: Acyline (GnRH antagonist)
Number of subjects: 53
Study 15611571 — intervention group
Group type: COMPARATOR
Intervention: Testosterone replacement with acyline
Number of subjects: 53
Study 12039110 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 microgram of 17 beta‐E2
Number of subjects: 58
Study 12039110 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microgram of 17 beta‐E2
Number of subjects: 58
Study 9003858 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (50 mg/day)
Number of subjects: 56
Study 9003858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 7963304 — intervention group
Group type: EXPERIMENTAL
Intervention: Epineurotomy
Number of subjects: 33
Study 7963304 — intervention group
Group type: COMPARATOR
Intervention: Control (non‐epineurotomy)
Number of subjects: 33
Study 3625243 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant CMF (cyclophosphamide, methotrexate, and fluorouracil)
Number of subjects: 845
Study 3625243 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 845
Study 30036166 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Telemonitoring (HTM) with weekly video televisits and daily vital sign monitoring
Number of subjects: 89
Study 30036166 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive Outpatient Management (COM) with weekly telephone contact
Number of subjects: 89
Study 29374412 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat consumption
Number of subjects: 1060
Study 29374412 — intervention group
Group type: EXPERIMENTAL
Intervention: High consumption of vegetables
Number of subjects: 1060
Study 29374412 — intervention group
Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 1060
Study 29374412 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive FIT results (cut-off 100 ng/mL)
Number of subjects: 1060
Study 26529073 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap (tetanus, diphtheria acellular pertussis) vaccine
Number of subjects: 0
Study 26529073 — intervention group
Group type: COMPARATOR
Intervention: Tetanus only vaccine (Control)
Number of subjects: 0
Study 24781761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation plus zoledronic acid
Number of subjects: 84
Study 24781761 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid alone
Number of subjects: 84
Study 24781761 — intervention group
Group type: COMPARATOR
Intervention: Cryoablation alone
Number of subjects: 84
Study 22976996 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary cycling
Number of subjects: 64
Study 22976996 — intervention group
Group type: COMPARATOR
Intervention: Walking exercise
Number of subjects: 64
Study 19996755 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 103
Study 19996755 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 103
Study 19996755 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HTTLPR (biomarker)
Number of subjects: 103
Study 17555928 — intervention group
Group type: EXPERIMENTAL
Intervention: E/E' ratio of early tricuspid inflow to annular diastolic velocity
Number of subjects: 101
Study 17555928 — intervention group
Group type: EXPERIMENTAL
Intervention: E/E' ≥ 4
Number of subjects: 101
Study 17555928 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of greater than 2 in E/E'
Number of subjects: 101
Study 15701590 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS063D (Atopiclair)
Number of subjects: 30
Study 12757067 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.3 mg in normal saline 0.3 ml
Number of subjects: 40
Study 12757067 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 0.3 ml
Number of subjects: 40
Study 11087061 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy enhancement group
Number of subjects: 56
Study 11087061 — intervention group
Group type: EXPERIMENTAL
Intervention: Tutorial training group
Number of subjects: 56
Study 11087061 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 8883232 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg dolasetron mesilate
Number of subjects: 50
Study 8883232 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg dolasetron mesilate
Number of subjects: 50
Study 8883232 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 mg/kg dolasetron mesilate
Number of subjects: 50
Study 8883232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 8883232 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate (all doses pooled)
Number of subjects: 50
Study 8883232 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate
Number of subjects: 50
Study 1589561 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 IU/kg salmon calcitonin (sCT)
Number of subjects: 12
Study 1589561 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 IU/kg salmon calcitonin (sCT)
Number of subjects: 12
Study 1589561 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 12
Study 1589561 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of sCT
Number of subjects: 12
Study 3890825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimozide
Number of subjects: 8
Study 3890825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3654291 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog activity sessions
Number of subjects: 66
Study 3654291 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog activity sessions (12 weeks) followed by other activity (12 weeks)
Number of subjects: 66
Study 3654291 — intervention group
Group type: COMPARATOR
Intervention: Other activity sessions
Number of subjects: 66
Study 30391445 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) at maximum flow rate of 60 LPM and FiO2 of 0.36-0.40
Number of subjects: 59
Study 30391445 — intervention group
Group type: COMPARATOR
Intervention: Standard Nasal Cannula (SNC) at 4 LPM
Number of subjects: 59
Study 28385659 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide 0.5 mg once weekly
Number of subjects: 1225
Study 28385659 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide 1.0 mg once weekly
Number of subjects: 1225
Study 28385659 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 1225
Study 25744362 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing xylitol gum (n = 27)
Number of subjects: 55
Study 25744362 — intervention group
Group type: COMPARATOR
Intervention: No gum (control group, n = 28)
Number of subjects: 55
Study 23743108 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of magnetic positioning device (UPD) during colonoscopy
Number of subjects: 1068
Study 23743108 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy without UPD
Number of subjects: 1068
Study 21343937 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-sampling kit
Number of subjects: 3000
Study 21343937 — intervention group
Group type: COMPARATOR
Intervention: Further invitation to attend for cervical cytology
Number of subjects: 3000
Study 21343937 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV positive women
Number of subjects: 3000
Study 19730273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for suicide prevention (CBT-SP)
Number of subjects: 110
Study 16581479 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive Doppler tissue imaging (CMM DTI)
Number of subjects: 27
Study 15318465 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl 2.5 microg kg(‐1) during induction (Groups 2 and 4)
Number of subjects: 120
Study 15318465 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline solution during induction (Groups 1 and 3)
Number of subjects: 120
Study 10770181 — intervention group
Group type: EXPERIMENTAL
Intervention: Leu7Pro polymorphism (Pro7 substitution) in boys
Number of subjects: 688
Study 9395949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiotomy suction (CTR) system
Number of subjects: 16
Study 9395949 — intervention group
Group type: COMPARATOR
Intervention: Cell-saver (CS)
Number of subjects: 16
Study 8416595 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled compression
Number of subjects: 109
Study 8416595 — intervention group
Group type: COMPARATOR
Intervention: Technologist-controlled compression
Number of subjects: 109
Study 3602017 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg bendroflumethiazide plus 15 mmol potassium chloride
Number of subjects: 78
Study 3602017 — intervention group
Group type: COMPARATOR
Intervention: 50 mg hydrochlorothiazide plus 5 mg amiloride
Number of subjects: 78
Study 3602017 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 78
Study 29464338 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-magnesium-bicarbonate content in thermal mineral water
Number of subjects: 0
Study 29464338 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 27421987 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable Partial Dentures (RPDs)
Number of subjects: 55
Study 27421987 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened Dental Arch (SDA)
Number of subjects: 55
Study 27421987 — intervention group
Group type: COMPARATOR
Intervention: functionally orientated treatment (SDA)
Number of subjects: 55
Study 27421987 — intervention group
Group type: COMPARATOR
Intervention: Dental implant treatment
Number of subjects: 55
Study 25035882 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook use
Number of subjects: 960
Study 25035882 — intervention group
Group type: COMPARATOR
Intervention: Alternate internet site
Number of subjects: 960
Study 22933438 — intervention group
Group type: EXPERIMENTAL
Intervention: IDegAsp
Number of subjects: 548
Study 20843224 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 µg/kg/hr
Number of subjects: 13
Study 20843224 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 µg/kg/hr
Number of subjects: 13
Study 19253506 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulization
Number of subjects: 54
Study 19253506 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI with Volumatic spacer
Number of subjects: 54
Study 19253506 — intervention group
Group type: EXPERIMENTAL
Intervention: DPI (Easyhaler)
Number of subjects: 54
Study 16201856 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled family-based health education/counseling intervention (5 counseling sessions)
Number of subjects: 1055
Study 16201856 — intervention group
Group type: COMPARATOR
Intervention: Control group 1 (no counseling)
Number of subjects: 1055
Study 16201856 — intervention group
Group type: COMPARATOR
Intervention: Control group 2 (no counseling)
Number of subjects: 1055
Study 12617332 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous ultra‐filtration (UF GROUP)
Number of subjects: 16
Study 12617332 — intervention group
Group type: COMPARATOR
Intervention: Isovolemic phase with sequential ultra‐filtration (ISO GROUP)
Number of subjects: 16
Study 10334412 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine bicycle exercise echocardiography (SBE)
Number of subjects: 74
Study 10334412 — intervention group
Group type: COMPARATOR
Intervention: Post-treadmill exercise echocardiography (TME)
Number of subjects: 74
Study 7491878 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplement (17.85 mmol (714 mg)/d)
Number of subjects: 25
Study 7491878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 7491878 — intervention group
Group type: COMPARATOR
Intervention: UK mothers (high-calcium diet)
Number of subjects: 25
Study 1697334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal natural beta-IFN
Number of subjects: 16
Study 1697334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 6267617 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam/pivampicillin (200 mg pivmecillinam and 250 mg pivampicillin, twice daily for 10 days)
Number of subjects: 42
Study 6267617 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole (800 mg sulphamethoxazole plus 160 mg trimethoprim, twice daily for 10 days)
Number of subjects: 42
Study 30097056 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study 30097056 — intervention group
Group type: COMPARATOR
Intervention: Balanced control condition
Number of subjects: 0
Study 30097056 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (SSRI)
Number of subjects: 0
Study 27505611 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg dried ginger capsules twice daily
Number of subjects: 63
Study 27505611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 24158762 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with Coenzyme Q10
Number of subjects: 20
Study 24158762 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 20
Study 24158762 — intervention group
Group type: COMPARATOR
Intervention: Saturated fatty acid-rich diet
Number of subjects: 20
Study 22920077 — intervention group
Group type: EXPERIMENTAL
Intervention: Pollen grains plus starch granules
Number of subjects: 30
Study 22920077 — intervention group
Group type: EXPERIMENTAL
Intervention: Starch granules only
Number of subjects: 30
Study 22920077 — intervention group
Group type: COMPARATOR
Intervention: Pollen grains
Number of subjects: 30
Study 20133927 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 40
Study 17478068 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles Insight QUS imaging device
Number of subjects: 60
Study 17478068 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone mineral density (BMD) measurements using Lunar Prodigy DXA scanner
Number of subjects: 60
Study 17478068 — intervention group
Group type: COMPARATOR
Intervention: Comparison of BMD and QUS variables
Number of subjects: 60
Study 16331126 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise at 60-70% of age-predicted maximal heart rate for 30 min
Number of subjects: 40
Study 16331126 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest for 30 min
Number of subjects: 40
Study 11948834 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiMARK
Number of subjects: 1684
Study 11948834 — intervention group
Group type: COMPARATOR
Intervention: Magnevist
Number of subjects: 1684
Study 11948834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1684
Study 9655642 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet applied (tourniquet group)
Number of subjects: 97
Study 9655642 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet applied (non-tourniquet group)
Number of subjects: 97
Study 8595643 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily
Number of subjects: 0
Study 8595643 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 5 mg once daily (titrated to 10 mg after 4 weeks)
Number of subjects: 0
Study 2914082 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium (KCl; 20 mEq three times daily)
Number of subjects: 14
Study 2914082 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 14
Study 2914082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2914082 — intervention group
Group type: COMPARATOR
Intervention: Oral calcium (Ca; 500 mg twice daily)
Number of subjects: 14
Study 2914082 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 14
Study 30582240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin, fluorouracil, and docetaxel followed by concurrent chemoradiotherapy
Number of subjects: 108
Study 27230861 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based cognitive intervention (GCI)
Number of subjects: 293
Study 27230861 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cognitive intervention (HCI)
Number of subjects: 293
Study 27230861 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 293
Study 25487930 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion (0.05-0.1 µg·kg‐1·min‐1)
Number of subjects: 24
Study 25487930 — intervention group
Group type: COMPARATOR
Intervention: Control group (no remifentanil)
Number of subjects: 24
Study 23025735 — intervention group
Group type: COMPARATOR
Intervention: General practice‐based health‐check with brief lifestyle counselling and referral to a program with one to two individual visits with an exercise physiologist or dietitian, and six group sessions.
Number of subjects: 655
Study 23025735 — intervention group
Group type: COMPARATOR
Intervention: Attended minimum number of group program sessions (117 patients, 30.5% of intervention group).
Number of subjects: 655
Study 23025735 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 655
Study 19484483 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg) every 28 days with high-dose radiotherapy
Number of subjects: 0
Study 19484483 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg) every 28 days with reduced-dose radiotherapy
Number of subjects: 0
Study 18728281 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors or ARBs
Number of subjects: 1051
Study 18728281 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors or ARBs initiated during the study
Number of subjects: 1051
Study 16483027 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran oil
Number of subjects: 14